106 related articles for article (PubMed ID: 8602984)
61. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
[TBL] [Abstract][Full Text] [Related]
62. Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma.
Cortelazzo S; Viero P; Bellavita P; Rossi A; Buelli M; Borleri GM; Marziali S; Bassan R; Comotti B; Rambaldi A
J Clin Oncol; 1995 Apr; 13(4):935-41. PubMed ID: 7535843
[TBL] [Abstract][Full Text] [Related]
63. Effect of G-CSF on peripheral blood progenitor cell mobilization and collection from healthy donors.
Chaisiripoomkere W; Jootar S; Ungkanont A
Asian Pac J Allergy Immunol; 2001 Sep; 19(3):183-90. PubMed ID: 11826913
[TBL] [Abstract][Full Text] [Related]
64. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
[TBL] [Abstract][Full Text] [Related]
65. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
Filip S; Bláha M; Odrázka K; Mericka P; Vávrová J
J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969
[TBL] [Abstract][Full Text] [Related]
66. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.
Mapara MY; Körner IJ; Hildebrandt M; Bargou R; Krahl D; Reichardt P; Dörken B
Blood; 1997 Jan; 89(1):337-44. PubMed ID: 8978310
[TBL] [Abstract][Full Text] [Related]
67. A prospective, randomized, sequential, crossover trial of large-volume versus normal-volume leukapheresis procedures: effect on progenitor cells and engraftment.
Humpe A; Riggert J; Munzel U; Repas-Humpe LM; Vehmeyer K; Brunner E; Wörmann B; Köhler M
Transfusion; 1999 Oct; 39(10):1120-7. PubMed ID: 10532607
[TBL] [Abstract][Full Text] [Related]
68. Highly effective CD34+ selection of granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood progenitor cells.
Schreiner T; Maccari B; Erne E; Bischof C; Wiesneth M
Blood; 1996 Aug; 88(4):1517-8. PubMed ID: 8695877
[No Abstract] [Full Text] [Related]
69. CD34+ cell immunoselection from G-CSF-alone-primed peripheral blood in children with low body mass.
Kanold J; Berger M; Rapatel C; de Lumley L; Lutz P; Plantaz D; Vannier JP; Bergeron C; Mechinaud F; Favrot M
Br J Haematol; 1995 Oct; 91(2):431-3. PubMed ID: 8547090
[TBL] [Abstract][Full Text] [Related]
70. High platelet contamination in progenitor cell concentrates results in significantly lower CD34+ yield after immunoselection.
Reiser M; Draube A; Scheid C; Fuchs M; Josting A; Diehl V; Söhngen D
Transfusion; 2000 Feb; 40(2):178-81. PubMed ID: 10686001
[TBL] [Abstract][Full Text] [Related]
71. Ex vivo expansion of hematopoietic progenitors from CD34+ cells selected from leukapheresis products of lymphoma and myeloma patients: feasibility and enhancement by fibronectin.
Mahé B; Pineau D; Robillard N; Accard F; Hermouet S
J Hematother; 1996 Dec; 5(6):671-9. PubMed ID: 9117256
[TBL] [Abstract][Full Text] [Related]
72. Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.
Vescio R; Schiller G; Stewart AK; Ballester O; Noga S; Rugo H; Freytes C; Stadtmauer E; Tarantolo S; Sahebi F; Stiff P; Meharchard J; Schlossman R; Brown R; Tully H; Benyunes M; Jacobs C; Berenson R; DiPersio J; Anderson K; Berenson J
Blood; 1999 Mar; 93(6):1858-68. PubMed ID: 10068658
[TBL] [Abstract][Full Text] [Related]
73. Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphoma.
Marin GH; Dal Cortivo L; Cayuela JM; Marolleau JP; Pautier P; Cojean-Zelek I; Brice P; Makke J; Benbunan M; Gisselbrecht C
Hematol Cell Ther; 1997 Feb; 39(1):33-40. PubMed ID: 9088936
[TBL] [Abstract][Full Text] [Related]
74. Estimation of the progenitor cell yield in a leukapheresis product by previous measurement of CD34+ cells in the peripheral blood.
Möhle R; Murea S; Pförsich M; Witt B; Haas R
Vox Sang; 1996; 71(2):90-6. PubMed ID: 8873418
[TBL] [Abstract][Full Text] [Related]
75. Combined isolation of CD34+ progenitor cells and reduction of B cells from peripheral blood by use of immunomagnetic methods.
Martín-Henao GA; Picón M; Rueda F; Amill B; Querol S; Gonzalez-Barca E; Ferrá C; Grañena A; García J
Transfusion; 2002 Jul; 42(7):912-20. PubMed ID: 12375665
[TBL] [Abstract][Full Text] [Related]
76. Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting system.
Voena C; Locatelli G; Castellino C; Omedè P; Ladetto M; Zappone E; Milani R; Perfetti V; Boccadoro M; Pileri A; Lusso P; Villa C; Malnati M; Corradini P
Br J Haematol; 2002 Jun; 117(3):642-5. PubMed ID: 12028036
[TBL] [Abstract][Full Text] [Related]
77. Linear reduction of clonal cells in stem cell enriched grafts in transplanted multiple myeloma.
Thunberg U; Bånghagen M; Bengtsson M; Christensen LD; Geisler CH; Gimsing P; Lenhoff S; Mortensen BT; Olofsson T; Simonsson B; Andersen NS; Sundström C; Swedin A; Sällström JF; Thuresson B; Westin J; Carlson K
Br J Haematol; 1999 Mar; 104(3):546-52. PubMed ID: 10086793
[TBL] [Abstract][Full Text] [Related]
78. Transplantation of CD34+ hematopoietic progenitor cells.
Berenson RJ; Shpall EJ; Auditore-Hargreaves K; Heimfeld S; Jacobs C; Krieger MS
Cancer Invest; 1996; 14(6):589-96. PubMed ID: 8951362
[TBL] [Abstract][Full Text] [Related]
79. Melphalan-mobilized blood stem cell components contain minimal clonotypic myeloma cell contamination.
Zhou P; Zhang Y; Martinez C; Kalakonda N; Nimer SD; Comenzo RL
Blood; 2003 Jul; 102(2):477-9. PubMed ID: 12649134
[TBL] [Abstract][Full Text] [Related]
80. Combined negative and positive selection of mobilized CD34 blood cells.
Di Nicola M; Bregni M; Siena S; Ruffini PA; Milanesi M; Ravagnani F; Gianni AM
Br J Haematol; 1996 Sep; 94(4):716-21. PubMed ID: 8826900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
